Tag: TenNor Therapeutics
TenNor Therapeutics gets FDA orphan drug status for TNP-2092 in prosthetic joint infections
TenNor Therapeutics has secured orphan drug designation from the US Food and Drug Administration (FDA) for its multitargeting drug conjugate TNP-2092 for the treatment of ... Read More